|
(Natural News) New research published in The New England Journal of Medicine (NEJM) suggests that a novel form of monoclonal antibodies could be a safe and effective cure for cancer. The results of the small trial are already being hailed as “remarkable” and “unprecedented” because all 18 participants are now cancer-free, thanks to receiving dostarlimab… |